claim to be GTR products either, if I am correct.
>Good for you Joel
>I'm tired of reading of these magic bullets which will eradicate
>periondontal disease.
>ie.
>Periochip with a possible .4 mm. of attachment gain.
>Emdogain with a possible 1mm. bone regeneration.
>Periostat with a long term intake of an antibiotic. What kind of
>superbugs with increased resistance to doxycycline will be produced?
>The multitude of guided tissue regeneration products with dubious long
>term substantive results.
>The next time a detail man comes to your door proclaiming the wonders
>of some product ask him this question. Can you assure me that I can
>use this product on a tooth with a 7 mm. intraboney defect and guarantee
>success so that the tooth can serve as an abutment for a 3 unit bridge.
>Watch the guy backpedal from his glowing descriptions of the product.
>Until. we can produce results as good as endodontists, periodontics
>has a long way to go.
>Richard Migicovsky
>> Trends in Dentistry
>> Just got this in today. Periodontal and preventive care.
>> Treatment phases: Antimicrobial therapy. 59% of the reporting
>> doctors use it!
>> "Periostat is exciting," Dr. Gutter said.
>> My question is, exciting for whom?
>> Dear Dr. Gutter. Just how thick is a dime anyway?
>> Cheers,
>> Joel
>> Joel M. Eichen, D.D.S.
>> ** ** **
>> Hello Zugumba and others:
>> Periostat
>> I have previously obtained abstracts including graphs and
>> charts detailing the effectiveness of Periostat. The reason
>> why I did this is that their 4-page full color ad in
>> practically every dental journal is slightly misleading.
>> I spent too many years poring over biochemistry research
>> publications to mess up now! When patients ask about
>> efficacy, I like to be able to speak definitely.
>> Periostat (CollaGenex Pharmaceuticals, Inc., Newtown, PA)
>> claims that,
>> 67% reduction in pocket depth seen within 3 months in
>> patients with severe disease (>=7mm) vs. SRP alone.
>> 52% gain in clinical attachment level seen within 3 months
>> in patients with severe disease (>=7mm) vs. SRP alone.
>> Now this is certainly true, however, I had to read and
>> reread this only to find out that I still did not know how
>> effective Periostat really is. What sorts of absolute pocket
>> depth reduction could my patients hope to obtain? This really
>> is the key, isn't it? Look at the numbers, not the
>> percentages!
>> Abstract # 2957
>> Adjunctive Use of Subantimicrobial Doxycycline Therapy for
>> Periodontitis - J Canton, S Ciancio, R Crout, A Hefti, and A
>> Polson. J Dental Res 1997;76 (abstr 1307).
>> (Multi-institutional study)
>> As example, in this study of 190 patients (94 and 96 patients
>> in respective treatment groups), 9 months out, SRP + placebo
>> (scaling, root planing plus placebo) the mean change in
>> clinical attachment level in tooth sites with severe disease
>> was 1.17 mm while the mean change of SRP + SDD (scaling and
>> root planing plus subantimicrobial dose of doxycyline) was
>> 1.55 mm. I believe this means that SRP plus SDD is 0.38 mm
>> more effective than SRP without SDD.
>> Mean change in pocket depth in tooth sites with severe
>> disease was 1.20 mm (SRP + placebo) versus 1.68 mm (SRP +
>> SDD) which represents 0.48 mm.
>> Recall that in both cases this improvement is around one half
>> the thickness of a dime! This is not a lot to write home
>> about is it? In fact, I do not know how to measure this.
>> What if I press too {*filter*}e time and not another time? Half
>> the thickness of a dime. Sheesh.
>> The figures for mild-to-moderate disease were somewhat less
>> than those for severe disease. If anyone is interested, I'll
>> post jpgs of the charts at sci.med.dentistry.
>> Cheers,
>> Joel
>> Joel M. Eichen, D.D.S.
>> Where does the 67% improvement (pocket reduction) come from?
>> 67% reduction in pocket depth seen within 3 months in
>> patients with severe disease (>=7mm) vs. SRP alone.
>> =====================================================
>> In this study SRP + placebo (3 months out) represents pocket
>> reduction of 0.91 mm. SRP + SDD (3 months out) represents
>> 1.38 mm. This is a difference of 0.47 mm which is around half
>> the thickness of a dime. 0.91 mm divided by 1.38 mm equals
>> 67% improvement! Hah!
>> I'm still looking for the magic bullet!
>> --------------------------------------
>> [background post: Shellah 2/5/99]
>> In reply to Shellah's question.
>> PREVIOUSLY-
>> I just got some prices from my dentist on these. The
>> Perio Chip was $150 per tooth and Antridox treatment
>> was $250 per tooth. Is there any difference is the
>> results of these two methods? Why would one cost that
>> much more? Have these been written up in any dental
>> journal I might read? Can anyone tell me which. Would
>> like to see if I can access it online or the library. I
>> really would like to get some statistics on these
>> treatments as compared to surgery. Are they available
>> from the manufacturers and are they unbiased?
>> As a lay person I'm trying to get some info on these,
>> aside from what a surgery-happy perio (periodontist) is
>> giving me.
>> Thanks!
>> ===================================
>> Reply:
>> Warning: These are prescription medications and should
>> not be administered where contraindicated. Read package
>> insert or literature!
>> -----------------------------------
>> Atridox --doxycycline hyclate 10.0%
>> Antimicrobial gel. Flows where chips and fibers won't
>> go.
>> In several well-controlled, multicenter studies, (1)
>> {*filter*}Hygiene and (2) Placebo reduced pocket depth in
>> the first month (0.4 mm reduction). (3) SRP and (4)
>> Atridox reduced pocket depth 0.6 to 0.7 mm in the first
>> month. Atridox did slightly better in subsequent
>> months. (0.4 to 0.6 mm additional pocket reduction).
>> Its placed with a blunt needle.
>> -----------------------
>> Periostat is doxycycline hyclate capsules - 20 mg.
>> Dosage: 20 mg twice a day for up to 9 months.
>> ----------------------
>> Perio Chip is chlorhexidine gluconate in a gelatin
>> chip.
>> This of course is the same active ingredient as
>> Hibiclens, antiseptic, antimicrobial skin cleanser.
>> If this therapy becomes popular, competition will drive
>> down the cost of the chip itself.
>> ----------------------